Why the study?
Does prophylactic administration of droperidol or ondansetron improve cost-effectiveness for preventing PONV compared to treating only symptomatic patients?
Does prophylactic administration of droperidol or ondansetron improve cost-effectiveness for preventing PONV compared to treating only symptomatic patients?
No takes yet. Share an insight, caveat, or question.
This editorial discusses a decision-analysis model evaluating the cost-effectiveness of prophylactic antiemetics versus symptomatic treatment for postoperative nausea and vomiting.
Mehernoor F. Watcha (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: